ClearFlow
Private Company
Funding information not available
Overview
ClearFlow is a private medical device company targeting complications in post-cardiac surgery recovery, primarily Retained Blood Syndrome (RBS). Its core technology, PleuraFlow, is a commercially available active chest tube clearance system clinically demonstrated to reduce RBS, postoperative atrial fibrillation, and ICU length of stay. Led by a seasoned executive team with clinical and commercial expertise, the company is focused on driving adoption in cardiac surgery centers through clinical evidence and integration into Enhanced Recovery After Surgery (ERAS) protocols.
Technology Platform
Active clearance technology for maintaining surgical drain (chest tube) patency to prevent post-operative complications like Retained Blood Syndrome.
Opportunities
Risk Factors
Competitive Landscape
Competition likely includes traditional passive chest tube systems (the standard of care being displaced) and potential emerging active clearance technologies. In sternal fixation, competition comes from established orthopedic and cardiac surgery device companies offering wires, plates, and cables. ClearFlow's differentiation is its specific focus on active clearance with strong clinical evidence for reducing Retained Blood Syndrome.